Search
Virax Biolabs Group Ltd
VRAXAdd to Watchlist
3.130USD
+0.390+14.23%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
13.59MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+14.23%
5 Days
+0.64%
1 Month
+1480.01%
6 Months
+715.10%
Year to Date
+805.15%
1 Year
+268.24%
Key Figures
2.700Open
3.130High
253.64KVolume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
5.84%Turnover Ratio
2.740Prev. Close
2.685Low
525.44KTurnover
LossP/E Static
2.39P/B
0.00%Div Yield TTM
-101.88%ROA
1.14052wk High
0.78Volume Ratio
-6.06MNet Profit
4.34MShares
-1.6248EPS TTM
1.26Beta
-109.58%ROE
0.10052wk Low
16.24%Amplitude
-3381.20%Gross Margin
13.59MMarket Cap
203.69Reward/Risk
6.30%Risk Rate
TradingKey Stock Score
No stock score available due to insufficient data.
Virax Biolabs Group Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Virax Biolabs Group Ltd Info
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is engaged in developing ViraxImmune with the intention of providing an immunology profiling platform that assesses each individual’s immune risk profile against global viral diseases as well as helping with the early diagnosis of post-viral syndromes associated with T cell exhaustion and chronic inflammation. Its product portfolio includes ViraxClear and ViraxVet. ViraxClear offers a range of accurate diagnostic testing kits and machines. ViraxVet offers various rapid and molecular tests for small animal veterinary diagnostics. The Company is initially focused on diseases associated with post-viral syndromes, including SARS-CoV-2, Human Papillomavirus (HPV), Malaria, Hepatitis B, and Herpes (HSV-1).
Ticker SymbolVRAX
CompanyVirax Biolabs Group Ltd
CEOFoster (James)
Websitehttps://www.viraxbiolabs.com
Related Instruments
+1.62%
+3.50%
+6.14%
+3.96%
+3.31%
+3.72%
+3.55%
+3.40%
+4.21%
+1.80%
+6.03%
+4.11%
+4.62%
+3.68%
+2.35%
0.00%
+4.73%
+3.32%
+0.41%
+4.98%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of Virax Biolabs Group Ltd (VRAX)?
The current price of Virax Biolabs Group Ltd (VRAX) is 3.13.
What is the symbol of Virax Biolabs Group Ltd?
The ticker symbol of Virax Biolabs Group Ltd is VRAX.
What is the 52-week high of Virax Biolabs Group Ltd?
The 52-week high of Virax Biolabs Group Ltd is 1.14.
What is the 52-week low of Virax Biolabs Group Ltd?
The 52-week low of Virax Biolabs Group Ltd is 0.10.
What is the market capitalization of Virax Biolabs Group Ltd?
The market capitalization of Virax Biolabs Group Ltd is 13.59M.
Is Virax Biolabs Group Ltd (VRAX) currently rated as Buy, Hold, or Sell?
According to analysts, Virax Biolabs Group Ltd (VRAX) has an overall rating of Buy, with a price target of 25.00.
What is the Earnings Per Share (EPS TTM) of Virax Biolabs Group Ltd (VRAX)?
The Earnings Per Share (EPS TTM) of Virax Biolabs Group Ltd (VRAX) is -1.62.